Assessment of cognitive scales to examine memory, executive function and language in individuals with down syndrome: Implications of a 6-month observational study

Frontiers in Behavioral Neuroscience

Volumn 9, Issue NOVEMBER, 2015, Pages

  d’Ardhuy, Xavier Liogier ^a   Edgin, Jamie O ^b   Bouis, Charles ^c   de Sola, Susana ^d   Goedner, Celia ^a   Kishnani, Priya ^e   Nöldeke, Jana ^a   Rice, Sydney ^f   Sacco, Silvia ^c   Squassante, Lisa ^a   Spiridigliozzi, Gail ^e   Visootsak, Jeannie ^g   Heller, James ^e   Khwaja, Omar ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b University of Arizona   (United States)

^c Institut Jerome Lejeune   (France)

^d HOSPITAL DEL MAR   (Spain)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g Hoffmann La Roche Ltd   (United States)

Author keywords

Clinical trial; Cognition; Down syndrome; Language; Outcome measure

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR RATING INVENTORY OF EXECUTIVE FUNCTION PRESCHOOL VERSION; CAMBRIDGE NEUROPSYCHOLOGICAL TEST AUTOMATED BATTERY; CHILD; CLINICAL EVALUATION OF LANGUAGE FUNDAMENTALS PRESCHOOL 2; COGNITION; DOWN SYNDROME; EXECUTIVE FUNCTION; FEMALE; HUMAN; LANGUAGE; LEITER INTERNATIONAL PERFORMANCE SCALE REVISED; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; OBSERVER MEMORY QUESTIONNAIRE PARENT FORM; PHASE 2 CLINICAL TRIAL (TOPIC); PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; SCHOOL CHILD;

EID: 84947716657     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2015.00300     Document Type: Article

References (53)

1. Aylward, E. H., Li, Q., Honeycutt, N. A., Warren, A. C., Pulsifer, M. B., Barta, P. E., et al. (1999). MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. Am. J. Psychiatry 1564, 564–568.
2. Bahn, S., Mimmack, M., Ryan, M., Caldwell, M. A., Jauniaux, E., Starkey, M., et al. (2002). Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet 359, 310–315. doi: 10.1016/S0140-6736(02)07497-4
3. Cantab Research Suite (2015). Cognitive Research. Available online at: http://www.camcog.com/en/science/tests (Retrieved 18 March, 2015).
4. Carlesimo, G. A., Marotta, L., and Vicari, S. (1997). Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia 35, 71–79.
5. Carr, J. (2012). Six weeks to 45 years: a longitudinal study of a population with Down syndrome. J. Appl. Res. Intellect. Disabil. 25, 414–422. doi: 10.1111/j.1468-3148.2011.00676.x
6. Carr, J. H. (1995). Down's Syndrome: Children Growing Up. Cambridge: Cambridge University Press.
7. Centers for Disease Control and Prevention. (2015). Official MADDSP and MADDS Surveillance Case Definitions: Metropolitan Atlanta Developmental Disabilities Surveillance Program (MADDSP) Case Definitions. Available online at: http://www.cdc.gov/ncbddd/developmentaldisabilities/casedefinitions.html (Retrieved June 8, 2015).
8. Centers for Medicare and Medicaid Services. (2014). ICD-9-CM Diagnosis and Procedure Codes: Abbreviated and Full Code Titles. Available online at: http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html (Retrieved June 8, 2015).
9. Chapman, R. S., and Hesketh, L. J. (2000). Behavioral phenotype of individuals with Down syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 6, 84–95. doi: 10.1002/1098-2779(2000)6: 84:AID-MRDD23.0.CO;2-P
10. Chaytor, N., and Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills. Neuropsychol. Rev. 13, 181–197. doi: 10.1023/B:NERV.0000009483.91468.fb
11. Cicchetti, D. V., and Sparrow, S. A. (1981). Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am. J. Ment. Defic. 86, 127–137.
12. Colas, D., Chuluun, B., Warrier, D., Blank, M., Wetmore, D. Z., Buckmaster, P., et al. (2013). Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome. Br. J. Pharmacol. 169, 963–973. doi: 10.1111/bph.12169
13. del Valle Rubido, M., Liogier d'Ardhuy, X., De La Torre, R., Dorison, N., Edgin, J., Kishnani, P., et al. (2014). Assessment of working memory in intellectual and development disabilities: results from a 6-month global longitudinal observational study in teenagers and young adults with down syndrome,” in Paper Presented at the American Association on Intellectual and Developmental Disabilities, Orlando, FL, USA (Orlando, FL)
14. de Sola, S., de la Torre, R., Sánchez-Benavides, G., Benejam, B., Cuenca-Royo, A., Del Hoyo, L., et al. (2015). A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials. Front. Psychol. 6:708. doi: 10.3389/fpsyg.2015.00708
15. Duff, K., Hobson, V. L., Beglinger, L. J., and O'Bryant, S. E. (2010). Diagnostic accuracy of the RBANS in mild cognitive impairment: limitations on assessing milder impairments. Arch. Clin. Neuropsychol. 25, 429–441. doi: 10.1093/arclin/acq045
16. Edgin, J., Clark, C., Massand, E., and Karmiloff-Smith, A. (2015). Building an adaptive brain across development: targets for neurorehabilitation must begin in infancy. Front. Behav. Neurosci. 9:232. doi: 10.3389/fnbeh.2015.00232
17. Edgin, J. O., Mason, G. M., Allman, M. J., Capone, G. T., Deleon, I., Maslen, C., et al. (2010a). Development and validation of the Arizona Cognitive Test Battery for Down syndrome. J. Neurodev. Disord. 2, 149–164. doi: 10.1007/s11689-010-9054-3
18. Edgin, J. O., Pennington, B. F., and Mervis, C. B. (2010b). Neuropsychological components of intellectual disability: the contributions of immediate, working, and associative memory. J. Intellect. Disabil. Res. 54, 406–417. doi: 10.1111/j.1365-2788.2010.01278.x
19. Edgin, J. O., Spanò, G., Kawa, K., and Nadel, L. (2014). Remembering things without context: development matters. Child Dev. 85, 1491–1502. doi: 10.1111/cdev.12232
20. Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., et al. (2007). Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 10, 411–413. doi: 10.1038/nn1860
21. Gioia, G. A., Isquith, P. K., Guy, S. C., and Kenworthy, L. (2000). Behavior rating inventory of executive function. Child Neuropsychol. 6, 235–238. doi: 10.1076/chin.6.3.235.3152
22. Gonzalez, L. M., Anderson, V. A., Wood, S. J., Mitchell, L. A., Heinrich, L., and Harvey, A. S. (2008). The observer memory questionnaire-parent form: introducing a new measure of everyday memory for children. J. Int. Neuropsychol. Soc. 14, 337–342. doi: 10.1017/S135561770808020X
23. Heller, J. H., Spiridigliozzi, G. A., Crissman, B. G., Sullivan-Saarela, J. A., Li, J. S., and Kishnani, P. S. (2006). Clinical trials in children with Down syndrome: issues from a cognitive research perspective. Am. J. Med. Genet. C Semin. Med. Genet. 142C, 187–195. doi: 10.1002/ajmg.c.30103
24. Hobson, V. L., Hall, J. R., Humphreys-Clark, J. D., Schrimsher, G. W., and O'Bryant, S. E. (2010). Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS). Int. J. Geriatr. Psychiatry 25, 525–530. doi: 10.1002/gps.2382
25. Jarrold, C., Nadel, L., and Vicari, S. (2008). Memory and Neuropsychology in Down syndrome. Down syndrome education on-line (Portsmouth, UK). (Retrieved 19 March, 2015). doi: 10.3104/reviews.2068. Available online at: http://www.down-syndrome.org/reviews/2068/reviews-2068.pdf
26. Jarrold, C., Purser, H. R. M., and Brock, J. (2006). “Short-term memory in Down syndrome,” in Working Memory and Neurodevelopmental Disorders, ed T. P. A. S. Gathercole (Hove: Psychology Press), 239–266.
27. Kesslak, J. P., Nagata, S. F., Lott, I., and Nalcioglu, O. (1994). Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome. Neurology 44, 1039–1045.
28. Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., and Mobley, W. C. (2004). Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 24, 8153–8160. doi: 10.1523/JNEUROSCI.1766-04.2004
29. Lanfranchi, S., Baddeley, A., Gathercole, S., and Vianello, R. (2012). Working memory in Down syndrome: is there a dual task deficit? J. Intellect. Disabil. Res. 56, 157–166. doi: 10.1111/j.1365-2788.2011.01444.x
30. Lanfranchi, S., Jerman, O., Dal Pont, E., Alberti, A., and Vianello, R. (2010). Executive function in adolescents with Down Syndrome. J. Intellect. Disabil. Res. 54, 308–319. doi: 10.1111/j.1365-2788.2010.01262.x
31. Lee, N. R., Fidler, D. J., Blakeley-Smith, A., Daunhauer, L., Robinson, C., and Hepburn, S. L. (2011). Caregiver report of executive functioning in a population-based sample of young children with Down syndrome. Am. J. Intellect. Dev. Disabil. 116, 290–304. doi: 10.1352/1944-7558-116.4.290
32. Liogier d'Ardhuy, X., Spychaj, L., Nave, S., and Khwaja, O. (2013). “Clinical drug development in down syndrome: exploratory assessments,” in Paper Presented at the Cognition in Down syndrome: Molecular, Cellular and Behavioral Features and the Promise of Pharmacotherapeutics, Washington, DC, USA (Washington, DC).
33. Lott, I. T., and Dierssen, M. (2010). Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol. 9, 623–633. doi: 10.1016/S1474-4422(10)70112-5
34. Määttä, T., Tervo-Määttä, T., Taanila, A., Kaski, M., and Iivanainen, M. (2006). Mental health, behaviour and intellectual abilities of people with Down syndrome. Downs. Syndr. Res. Pract. 11, 37–43. doi: 10.3104/reports.313
35. Martínez-Cué, C., Martínez, P., Rueda, N., Vidal, R., Garcia, S., Vidal, V., et al. (2013). Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome. J. Neurosci. 33, 3953–3966. doi: 10.1523/JNEUROSCI.1203-12.2013
36. Miller, J. F. (1998). Profiles of Language Development in Children with Down syndrome. Baltimore, MD: Paul H. Brookes.
37. Nadel, L. (2003). Down's syndrome: a genetic disorder in biobehavioral perspective. Genes Brain Behav. 2, 156–166. doi: 10.1034/j.1601-183X.2003.00026.x
38. Oremus, M., Oremus, C., Hall, G. B., and McKinnon, M. C. (2012). Inter-rater and test-retest reliability of quality assessments by novice student raters using the Jadad and Newcastle-Ottawa Scales. BMJ Open 2:e001368. doi: 10.1136/bmjopen-2012-001368
39. Parker, S. E., Mai, C. T., Canfield, M. A., Rickard, R., Wang, Y., Meyer, R. E., et al. (2010). Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res. A Clin. Mol. Teratol. 88, 1008–1016. doi: 10.1002/bdra.20735
40. Pearson (2004). Clinical Evaluation of Language Fundamentals®-Preschool-2 (CELF®-Preschool-2). Available online at: http://www.pearsonclinical.com/language/products/100000316/celf-preschool-2-celfpreschool2.html?Pid=015-8034-945&Mode=summary
41. Pennington, B. F., Moon, J., Edgin, J., Stedron, J., and Nadel, L. (2003). The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev. 74, 75–93. doi: 10.1111/1467-8624.00522
42. Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G. T., and Reiss, A. L. (2001). Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am. J. Psychiatry 158, 1659–1665. doi: 10.1176/appi.ajp.158.10.1659
43. Potier, M. C., Braudeau, J., Dauphinot, L., and Delatour, B. (2014). Reducing GABAergic inhibition restores cognitive functions in a mouse model of Down syndrome. CNS Neurol. Disord. Drug Targets 13, 8–15. doi: 10.2174/18715273113126660185
44. ™. Available online at: http://images.pearsonclinical.com/images/PDF/technical_reports/RBANS.pdf (Retrieved June 3, 2015).
45. Randolph, C., Tierney, M. C., Mohr, E., and Chase, T. N. (1998). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 20, 310–319. doi: 10.1076/jcen.20.3.310.823
46. Raz, N., Torres, I. J., Briggs, S. D., Spencer, W. D., Thornton, A. E., Loken, W. J., et al. (1995). Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45, 356–366.
47. Roid, G.H., and Miller, L.J. (1997). Leiter International Performance Scale-Revised: Examiner's Manual. Wood Dale, IL: Stoelting Co.
48. Schmidt-Sidor, B., Wisniewski, K. E., Shepard, T. H., and Sersen, E. A. (1990). Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin. Neuropathol. 9, 181–190.
49. Silverman, W. (2007). Down syndrome: cognitive phenotype. Ment. Retard. Dev. Disabil. Res. Rev., 13, 228–236. doi: 10.1002/mrdd.20156
50. U.S. Department of Health and Human Services and National Institutes of Health. (2014). National Institutes of Health Research Plan on Down Syndrome: Down Syndrome Directions. Available online at: https://www.nichd.nih.gov/publications/pubs/Documents/DSResearchPlan_2014.pdf
51. Vicari, S. (2001). Implicit versus explicit memory function in children with Down and Williams syndrome. Downs. Syndr. Res. Pract. 7, 35–40. doi: 10.3104/reports.112
52. World Health Organization (WHO) (2015). Genomic Resource Centre: Genes and Human Disease, Genes and Chromosomal Diseases. Available online at: http://www.who.int/genomics/public/geneticdiseases/en/index1.html (Retrieved June 3, 2015).
53. Zigman, W. B., Devenny, D. A., Krinsky-McHale, S. J., Jenkins, E. C., Urv, T. K., Wegiel, J., et al. (2008). Alzheimer's disease in adults with Down syndrome. Int. Rev. Res. Ment. Retard. 36, 103–145. doi: 10.1016/S0074-7750(08)00004-9